Vernia P - Search Results

1

Leukocytapheresis in the treatment of inflammatory bowel disease: Current position and perspectives.

Vernia P, D'Ovidio V, Meo D. Vernia P, et al. Transfus Apher Sci. 2010 Oct;43(2):227-9. doi: 10.1016/j.transci.2010.07.023. Transfus Apher Sci. 2010. PMID: 20817610 Review.

2

Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresis.

D'Ovidio V, Meo D, Viscido A, Bresci G, Vernia P, Caprilli R. D'Ovidio V, et al. Among authors: vernia p. World J Gastroenterol. 2011 Apr 14;17(14):1831-5. doi: 10.3748/wjg.v17.i14.1831. World J Gastroenterol. 2011. PMID: 21528055 Free PMC article.

3

Ulcerative colitis and granulocyte-monocyte-apheresis: safety and efficacy of maintenance therapy during pregnancy.

D'Ovidio V, Meo D, Gozer M, Bazuro ME, Vernia P. D'Ovidio V, et al. Among authors: vernia p. J Clin Apher. 2015 Feb;30(1):55-7. doi: 10.1002/jca.21349. Epub 2014 Sep 2. J Clin Apher. 2015. PMID: 25181523

4

Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy.

D'Ovidio V, Vernia P, Gentile G, Capobianchi A, Marcheggiano A, Viscido A, Martino P, Caprilli R. D'Ovidio V, et al. Among authors: vernia p. J Clin Virol. 2008 Oct;43(2):180-3. doi: 10.1016/j.jcv.2008.06.002. Epub 2008 Jul 9. J Clin Virol. 2008. PMID: 18614396

5

An unusual complicated polypectomy and inverted colonic diverticula.

D'Ovidio V, Di Camillo M, Pimpo MT, Meo D, Vernia P, Caprilli R. D'Ovidio V, et al. Among authors: vernia p. Colorectal Dis. 2010 May;12(5):491-2. doi: 10.1111/j.1463-1318.2009.01864.x. Epub 2009 Apr 10. Colorectal Dis. 2010. PMID: 19486101 No abstract available.

6

Dietary calcium intake in patients with inflammatory bowel disease.

Vernia P, Loizos P, Di Giuseppantonio I, Amore B, Chiappini A, Cannizzaro S. Vernia P, et al. J Crohns Colitis. 2014 Apr;8(4):312-7. doi: 10.1016/j.crohns.2013.09.008. Epub 2013 Oct 3. J Crohns Colitis. 2014. PMID: 24090907

7

Azathioprine treatment in inflammatory bowel disease patients: type and time of onset of side effects.

Avallone EV, Pica R, Cassieri C, Zippi M, Paoluzi P, Vernia P. Avallone EV, et al. Among authors: vernia p. Eur Rev Med Pharmacol Sci. 2014;18(2):165-70. Eur Rev Med Pharmacol Sci. 2014. PMID: 24488903 Free article.

8

Inadequate sunlight exposure in patients with inflammatory bowel disease.

Vernia P, Burrelli Scotti G, Dei Giudici A, Chiappini A, Cannizzaro S, Afferri MT, de Carolis A. Vernia P, et al. J Dig Dis. 2018 Jan;19(1):8-14. doi: 10.1111/1751-2980.12567. J Dig Dis. 2018. PMID: 29251424

9

Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients.

Zippi M, Corrado C, Pica R, Avallone EV, Cassieri C, De Nitto D, Paoluzi P, Vernia P. Zippi M, et al. Among authors: vernia p. World J Gastroenterol. 2014 Dec 14;20(46):17463-7. doi: 10.3748/wjg.v20.i46.17463. World J Gastroenterol. 2014. PMID: 25516659 Free PMC article.

10

Pathogenetic mechanisms of inflammatory bowel disease.

Caprilli R, Peña A, Dianzani F, Pallone F, Vernia P. Caprilli R, et al. Among authors: vernia p. Ital J Gastroenterol. 1995 Jul-Aug;27(6):313-26. Ital J Gastroenterol. 1995. PMID: 8562998 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page